Center for Devices and Radiological Health, U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD, 20993, USA.
Ther Innov Regul Sci. 2023 Sep;57(5):952-956. doi: 10.1007/s43441-023-00505-5. Epub 2023 Jun 9.
Nearly ubiquitous use of personal electronics, wearable sensors, and other types of digital health technologies, along with wireless connectivity, makes the capture of health data directly from an individual easier, enabling the use of patient-generated health data (PGHD) as a potential bridge between a patient's home and the healthcare system. This type of real-world data may be a completely new type of information, or it may be a more frequent collection of traditional information over longer time periods to form a longitudinal view of a patient's health status that can inform decision-making in clinical, medical product regulatory, and coverage and reimbursement settings. The U.S. Food and Drug Administration's Center for Devices and Radiological Health (CDRH) has been exploring and advancing the collection and use of PGHD since 2016, hosting a public meeting on the topic in May 2021. This manuscript presents highlights from various discussions at this meeting including those on the importance of stakeholder engagement, characteristics of high data quality, and PGHD in practice in patient-driven registries, as well as a look forward to some of the opportunities in the field.
个人电子产品、可穿戴传感器和其他类型的数字健康技术的广泛使用,以及无线连接,使得直接从个人身上获取健康数据变得更加容易,从而使患者生成的健康数据 (PGHD) 成为患者家庭和医疗保健系统之间的潜在桥梁。这种类型的真实世界数据可能是一种全新类型的信息,也可能是在更长时间内更频繁地收集传统信息,形成患者健康状况的纵向视图,从而为临床、医疗产品监管以及覆盖范围和报销设置中的决策提供信息。美国食品和药物管理局的设备和放射健康中心 (CDRH) 自 2016 年以来一直在探索和推进 PGHD 的收集和使用,并于 2021 年 5 月就该主题举办了一次公开会议。本文介绍了此次会议的各种讨论要点,包括利益相关者参与的重要性、高质量数据的特征以及患者驱动的注册中心中 PGHD 的实际应用,并展望了该领域的一些机会。